| Patent application number | Description | Published |
|---|
| 20090131845 | METHODS FOR THE TREATMENT OR PREVENTION OR SCARS AND/OR KELOIDS - Devices, bandages, kits and methods are described that can control or regulate the mechanical environment of a wound to ameliorate scar and/or keloid formation. The mechanical environment of a wound includes stress, strain, and any combination of stress and strain. The control of a wound's mechanical environment can be active, passive, dynamic, or static. The devices are configured to be removably secured to a skin surface in proximity to the wound site and shield the wound from endogenous and/or exogenous stress. | 05-21-2009 |
| 20090131846 | TREATMENT OR PREVENTION OF SCARS AND/OR KELOIDS - Devices, bandages, kits and methods are described that can control or regulate the mechanical environment of a wound to ameliorate scar and/or keloid formation. The mechanical environment of a wound includes stress, strain, and any combination of stress and strain. The control of a wound's mechanical environment can be active, passive, dynamic, or static. The devices are configured to be removably secured to a skin surface in proximity to the wound site and shield the wound from endogenous and/or exogenous stress. | 05-21-2009 |
| 20100092546 | Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds - Compositions and methods are provided for the treatment of chronic wounds, including, without limitation, pressure ulcers and diabetic ulcers, by transdermal delivery of an agent that increases activity of HIF-1α in the wound. Agents that increase HIF-1α activity include, without limitation, agents that stabilize HIF-1α, e.g. deferoxamine, deferiprone, deferasirox, etc.; agents that upregulate expression of HIF-1α, e.g. dimethyloxalylglycine, etc., HIF-1α polypeptide or coding sequences; and combinations thereof. Such agents may be referred to herein as HIF-1α potentiating agents. | 04-15-2010 |
| Patent application number | Description | Published |
|---|
| 20080262519 | COMPOSITIONS AND METHODS FOR JOINING NON-CONJOINED LUMENS - Disclosed are compositions, methods, and kits for joining together non-conjoined lumens in a patient's body including vascular lumens. More particularly, in various aspects, this invention provides compositions, methods, and kits for joining such non-conjoined lumens, including small lumens typically requiring microsurgical technique | 10-23-2008 |
| 20090065009 | Method and tools for the reduction of excess skin - Methods and devices for removing excess skin are described. The excess skin is gathered into a bundle, which is mechanically unloaded relative to the skin around the bundle. The bundle of excess skin is maintained for an extended period of time, such as at least three weeks, to permit the body to absorb some of the excess tissue. | 03-12-2009 |
| 20090187199 | COMPOSITIONS AND METHODS FOR JOINING NON-CONJOINED LUMENS - Disclosed are compositions, methods, and kits for joining together non-conjoined lumens in a patient's body including vascular lumens. More particularly, in various aspects, this invention provides compositions, methods, and kits for joining such non-conjoined lumens, including small lumens typically requiring microsurgical technique. | 07-23-2009 |
| 20100057056 | Methods and devices for improving the appearance of tissue - Cellulite is treated by severing septae, which interconnects the skin with the underlying muscle. The septae may be severed in connection with a liposuction procedure or independent of a liposuction procedure. | 03-04-2010 |
